## Core Concept
Pentasaccharides are a class of anticoagulant medications that work by inhibiting coagulation factor Xa. They are synthetic polysaccharides, specifically designed to mimic the binding site for heparin on antithrombin III but with a more predictable dose-response relationship. This mechanism is crucial for preventing thrombin formation without directly affecting thrombin.

## Why the Correct Answer is Right
The correct mechanism of action of pentasaccharides involves binding to antithrombin III, which then selectively inhibits factor Xa. This inhibition prevents the conversion of factor X to its active form, thereby reducing thrombin generation and subsequent clot formation. The specificity for factor Xa without affecting thrombin (factor IIa) directly distinguishes pentasaccharides from unfractionated heparin and low molecular weight heparins, which have broader anticoagulant activity.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not accurately describe the mechanism of action of pentasaccharides. Without specific details, it's hard to address directly, but given the context, it's clear that pentasaccharides work through antithrombin III to inhibit factor Xa, not through direct thrombin inhibition or other pathways.
- **Option B:** This option is incorrect as it also does not accurately represent the mechanism of pentasaccharides.
- **Option D:** This option is incorrect because it suggests a mechanism that does not align with the known action of pentasaccharides on coagulation factors.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that pentasaccharides, such as fondaparinux, have a predictable dose-response relationship, which eliminates the need for regular monitoring of anticoagulation levels, unlike unfractionated heparin. This makes them a convenient option for anticoagulation therapy. However, it's crucial to remember that their anticoagulant effect is reversible with recombinant factor VIIa in case of bleeding complications.

## Correct Answer: C. Inhibiting factor Xa through antithrombin III.